Literature DB >> 18428193

Potential role of mind-body therapies in cancer survivorship.

Daniel A Monti1, Meryl Sufian, Caroline Peterson.   

Abstract

The use of complementary and alternative medicine (CAM) by cancer survivors is high, particularly among those with psychosocial distress, poor quality of life, culturally based health beliefs, and those who experience health disparities in the mainstream healthcare system. As the number of cancer survivors continues to increase, so does the diversity of the survivorship population, making it increasingly important to understand and address the CAM culture in different survivor groups. Given the known communication barriers between cancer patients and their physicians regarding CAM, it would be useful for oncology providers to have a platform from which to discuss CAM-related issues. It is proposed that mind-body therapies with some basis in evidence could provide such a platform and also serve as a possible means of connecting cancer survivors to psychosocial supportive services. This article reviews a few mind-body therapies that may have particular relevance to cancer survivors, such as hypnosis and meditation practices. A theoretical foundation by which such therapies provide benefit is presented, with particular emphasis on self-regulation.

Entities:  

Mesh:

Year:  2008        PMID: 18428193     DOI: 10.1002/cncr.23443

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Authors:  Christoph Thomssen; Anton Scharl; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2011-08-30       Impact factor: 2.860

Review 2.  Mind-body therapies in integrative oncology.

Authors:  Gary Elkins; William Fisher; Aimee Johnson
Journal:  Curr Treat Options Oncol       Date:  2010-12

3.  A survey investigating the associations between self-management practices and quality of life in cancer survivors.

Authors:  C Shneerson; T Taskila; S Greenfield; N Gale
Journal:  Support Care Cancer       Date:  2015-02-12       Impact factor: 3.603

Review 4.  Mediators of change in psychosocial interventions for cancer patients: a systematic review.

Authors:  Anne Moyer; Matthew Goldenberg; Matthew A Hall; Sarah K Knapp-Oliver; Stephanie J Sohl; Elizabeth A Sarma; Stefan Schneider
Journal:  Behav Med       Date:  2012       Impact factor: 3.104

5.  A pilot feasibility and acceptability study of yoga/meditation on the quality of life and markers of stress in persons living with HIV who also use crack cocaine.

Authors:  Ram P Agarwal; Adarsh Kumar; John E Lewis
Journal:  J Altern Complement Med       Date:  2015-02-19       Impact factor: 2.579

6.  Mindfulness practice reduces cortisol blunting during chemotherapy: A randomized controlled study of colorectal cancer patients.

Authors:  David S Black; Cheng Peng; Alix G Sleight; Nathalie Nguyen; Heinz-Josef Lenz; Jane C Figueiredo
Journal:  Cancer       Date:  2017-04-07       Impact factor: 6.860

7. 

Authors:  Mansoureh Ashghali Farahani; Samira Soleimanpour; Samantha J Mayo; Jamie S Myers; Prabdeep Panesar; Farzaneh Ameri
Journal:  Can Oncol Nurs J       Date:  2022-02-01

8.  The effect of mind-body exercise on cognitive function in cancer survivors: A systematic review.

Authors:  Mansoureh Ashghali Farahani; Samira Soleimanpour; Samantha J Mayo; Jamie S Myers; Prabdeep Panesar; Farzaneh Ameri
Journal:  Can Oncol Nurs J       Date:  2022-02-01

9.  A pilot randomized controlled trial comparing the efficacy of exercise, spinal manipulation, and neuro emotional technique for the treatment of pregnancy-related low back pain.

Authors:  Caroline D Peterson; Mitchell Haas; W Thomas Gregory
Journal:  Chiropr Man Therap       Date:  2012-06-13

Review 10.  The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo.

Authors:  Marie Amitani; Haruka Amitani; Robert A Sloan; Hajime Suzuki; Nanami Sameshima; Akihiro Asakawa; Yasuhito Nerome; Tetsuhiro Owaki; Akio Inui; Etsuo Hoshino
Journal:  Front Pharmacol       Date:  2015-08-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.